Frontlight ResearchEarly access
Ulcerative colitis trials in Estonia
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in EstoniaStudy to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
- Where
- Parnu Linn, Tallinn
- Age
- 18 years to 75 years
- People
- 150 worldwide
- Run by
- Vanda Pharmaceuticals
See details and how to joinNCT07686081 · EU 2025-524520-22-00